Header Logo

MARTA PENAS-PRADO

TitleAssistant Professor
InstitutionMD Anderson
DepartmentNeuro-Oncology
Address1400 Holcombe Blvd
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rogers JL, Wall T, Acquaye-Mallory AA, Boris L, Kim Y, Aldape K, Quezado MM, Butman JA, Smirniotopoulos JG, Chaudhry H, Tsien CI, Chittiboina P, Zaghloul K, Aboud O, Avgeropoulos NG, Burton EC, Cachia DM, Dixit KS, Drappatz J, Dunbar EM, Forsyth P, Komlodi-Pasztor E, Mandel J, Ozer BH, Lee EQ, Ranjan S, Lukas RV, Raygada M, Salacz ME, Smith-Cohn MA, Snyder J, Soldatos A, Theeler BJ, Widemann BC, Camphausen KA, Heiss JD, Armstrong TS, Gilbert MR, Penas-Prado M. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors. J Neurooncol. 2024 Mar 01. PMID: 38427131.
      Citations:    Fields:    
    2. Briceno N, Vera E, Komlodi-Pasztor E, Abdullaev Z, Choi A, Grajkowska E, Kunst T, Levine J, Lindsley M, Fernandez K, Reyes J, Boris L, Burton E, Panzer M, Polskin L, Penas-Prado M, Pillai T, Theeler BJ, Wu J, Wall K, Papanicolau-Sengos A, Quezado M, Smirniotopoulos J, Aldape K, Armstrong TS, Gilbert MR. Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings. Neurooncol Adv. 2024 Jan-Dec; 6(1):vdae019. PMID: 38420614; PMCID: PMC10901543.
      Citations:    
    3. Price M, Neff C, Kruchko C, Barnholtz-Sloan JS, Cordeiro BB, Penas-Prado M, Ozer BH, Cimino PJ, Gilbert MR, Armstrong TS, Ostrom QT. Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT. J Neurooncol. 2023 Nov; 165(2):279-290. PMID: 37980692.
      Citations:    Fields:    Translation:Humans
    4. Pratt D, Penas-Prado M, Gilbert MR. Clinical impact of molecular profiling in rare brain tumors. Curr Opin Neurol. 2023 Dec 01; 36(6):579-586. PMID: 37973025.
      Citations:    Fields:    Translation:Humans
    5. Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NK. Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad032. PMID: 37114244; PMCID: PMC10129387.
      Citations:    
    6. King AL, Roche KN, Leeper HE, Vera E, Mendoza T, Mentges K, Acquaye-Mallory AA, Adegbesan KA, Boris L, Burton E, Choi A, Grajkowska E, Kunst T, Levine J, Lollo N, Miller H, Panzer M, Penas-Prado M, Pillai V, Polskin L, Reyes J, Sahebjam S, Stockdill ML, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial. J Neurooncol. 2023 Mar; 162(1):137-145. PMID: 36884201; PMCID: PMC9993385.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    7. Leeper HE, Vera E, Christ A, Acquaye A, Briceno N, Choi A, Grajkowska E, Jammula V, Levine J, Lindsley M, Reyes J, Roche KN, Rogers JL, Timmer M, Boris L, Burton E, Lollo N, Panzer M, Penas-Prado M, Pillai V, Polskin L, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. Association of Employment Status With Symptom Burden and Health-Related Quality of Life in People Living With Primary CNS Tumors. Neurology. 2023 04 18; 100(16):e1723-e1736. PMID: 36754634; PMCID: PMC10115506.
      Citations:    Fields:    Translation:Humans
    8. King AL, Roche KN, Leeper HE, Vera E, Mendoza T, Mentges K, Acquaye AA, Adegbesan K, Boris L, Burton E, Choi A, Grajkowska E, Kunst T, Levine J, Lollo N, Miller H, Panzer M, Penas-Prado M, Pillai V, Polskin L, Reyes J, Sahebjam S, Stockdill M, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial. Res Sq. 2023 Jan 31. PMID: 36789426; PMCID: PMC9928043.
      Citations:    
    9. Frederico SC, Vera E, Abdullaev Z, Acquaye A, Aldape K, Boris L, Briceno N, Choi A, Christ A, Cooper D, Grajkowska E, Kunst T, Leeper HE, Levine J, Lollo N, Pratt D, Quezado M, Shah R, Wall K, Gilbert MR, Armstrong TS, Penas-Prado M. Heterogeneous clinicopathological findings and patient-reported outcomes in adults with MN1-altered CNS tumors: A case report and systematic literature review. Front Oncol. 2023; 13:1099618. PMID: 36741001; PMCID: PMC9892899.
      Citations:    
    10. Bergsneider BH, Vera E, Gal O, Christ A, King AL, Acquaye A, Choi A, Leeper HE, Mendoza T, Boris L, Burton E, Lollo N, Panzer M, Penas-Prado M, Pillai T, Polskin L, Wu J, Gilbert MR, Armstrong TS, Celiku O. Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdac188. PMID: 36820236; PMCID: PMC9938652.
      Citations: 1     
    11. Robertson IJ, Gregory TA, Waguespack SG, Penas-Prado M, Majd NK. Recent Therapeutic Advances in Pituitary Carcinoma. J Immunother Precis Oncol. 2023 May; 6(2):74-83. PMID: 37214211; PMCID: PMC10195013.
      Citations: 1     
    12. Vera E, Christ A, Grajkowska E, Briceno N, Choi A, Crandon SK, Wall K, Lindsley M, Leeper HE, Levine J, Reyes J, Acquaye AA, King AL, Jammula V, Roche K, Rogers JL, Timmer M, Boris L, Lollo N, Panzer M, Polskin L, Pillai T, Burton E, Penas-Prado M, Theeler B, Gilbert MR, Armstrong TS, Mendoza TR. Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort study. EClinicalMedicine. 2023 Jan; 55:101718. PMID: 36386035; PMCID: PMC9661442.
      Citations: 2     
    13. Sass D, Vera E, Choi A, Acquaye A, Briceno N, Christ A, Grajkowska E, Jammula V, Levine J, Lindsley M, Reyes J, Roche K, Rogers JL, Timmer M, Boris L, Burton E, Lollo N, Panzer M, Penas-Prado M, Pillai V, Polskin L, Theeler BJ, Wu J, Gilbert MR, Armstrong TS, Leeper H. Evaluation of the key geriatric assessment constructs in primary brain tumor population - a descriptive study. J Geriatr Oncol. 2022 11; 13(8):1194-1202. PMID: 36041994; PMCID: PMC9691543.
      Citations:    
    14. King AL, Shuboni-Mulligan DD, Vera E, Crandon S, Acquaye AA, Boris L, Burton E, Choi A, Christ A, Grajkowska E, Jammula V, Leeper HE, Lollo N, Penas-Prado M, Reyes J, Theeler B, Wall K, Wu J, Gilbert MR, Armstrong TS. Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients. Neurooncol Pract. 2022 Dec; 9(6):526-535. PMID: 36388423; PMCID: PMC9665069.
      Citations: 2     
    15. Woodford R, Prather L, Helfer C, Davey L, Penas-Prado M, Armstrong T, Tucker K, Aldape K, Gilbert M, Clark C, Thavaneswaran S, Wang D, Mandel J, Kasherman L. Malignant melanocytic schwannian tumor and leptomeningeal disease: A case series with a focus on management. J Neurol Sci. 2022 07 15; 438:120291. PMID: 35635863.
      Citations:    Fields:    Translation:Humans
    16. Jammula V, Rogers JL, Vera E, Christ A, Leeper HE, Acquaye A, Briceno N, Choi A, Grajkowska E, Levine JE, Lindsley M, Reyes J, Roche KN, Timmer M, Boris L, Burton E, Lollo N, Panzer M, Smith-Cohn MA, Penas-Prado M, Pillai V, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments. Neurooncol Pract. 2022 Oct; 9(5):429-440. PMID: 36124322; PMCID: PMC9384084.
      Citations:    
    17. Leeper HE, Tonorezos E, Mayer D, Bakitas M, Chang S, Cooley ME, Hervey-Jumper S, Miaskowski C, Sherwood P, Tsien C, Wallgren K, Willmarth N, Arons D, Acquaye A, King AL, Penas-Prado M, Vera E, Gilbert MR, Armstrong TS, NCI-CONNECT Survivorship Care in Neuro-Oncology Workshop . Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT). Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac029. PMID: 35542753; PMCID: PMC9079897.
      Citations:    
    18. Shah R, Quezado M, Aboud O, Vera E, Burton E, Theeler B, Wu J, Boris L, Reyes J, Wall K, R Gilbert M, S Armstrong T, Penas-Prado M. Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology Branch. CNS Oncol. 2022 03 01; 11(1):CNS83. PMID: 35142534; PMCID: PMC8988255.
      Citations:    Fields:    Translation:Humans
    19. Mahajan A, Shih H, Penas-Prado M, Ligon K, Aldape K, Hu LS, Loughan AR, Basso MR, Leeper HE, Nahed BV, Stott SL, Geyer S, Giannini C, Galanis E. The Alliance AMBUSH Trial: Rationale and Design. Cancers (Basel). 2022 Jan 14; 14(2). PMID: 35053576; PMCID: PMC8773887.
      Citations:    
    20. Wooley JR, Penas-Prado M. Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age. Cancers (Basel). 2021 Dec 16; 13(24). PMID: 34944933; PMCID: PMC8699201.
      Citations:    
    21. Patil N, Somasundaram E, Waite KA, Lathia JD, Machtay M, Gilbert MR, Connor JR, Rubin JB, Berens ME, Buerki RA, Choi S, Sloan AE, Penas-Prado M, Ashby LS, Blumenthal DT, Werner-Wasik M, Hunter GK, Flickinger JC, Wendland MM, Panet-Raymond V, Robins HI, Pugh SL, Mehta MP, Barnholtz-Sloan JS. Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. J Neurooncol. 2021 Dec; 155(3):363-372. PMID: 34761331; PMCID: PMC8651582.
      Citations:    Fields:    Translation:HumansCells
    22. Penas-Prado M. Rare central nervous system tumors: the path to progress. Neuro Oncol. 2021 11 02; 23(23 Suppl 5):S1-S3. PMID: 34725695; PMCID: PMC8561122.
      Citations:    Fields:    Translation:Humans
    23. Weathers SP, Rood-Breithaupt J, de Groot J, Thomas G, Manfrini M, Penas-Prado M, Puduvalli VK, Zwingelstein C, Yung WKA. Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab141. PMID: 34693288; PMCID: PMC8528265.
      Citations:    
    24. Brown PD, Chung C, Liu DD, McAvoy S, Grosshans D, Al Feghali K, Mahajan A, Li J, McGovern SL, McAleer MF, Ghia AJ, Sulman EP, Penas-Prado M, de Groot JF, Heimberger AB, Wang J, Armstrong TS, Gilbert MR, Guha-Thakurta N, Wefel JS. A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma. Neuro Oncol. 2021 08 02; 23(8):1337-1347. PMID: 33647972; PMCID: PMC8328012.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    25. Majd NK, Mastall M, Lin H, Dibaj SS, Hess KR, Yuan Y, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harriso RA, De Groo JF, Puduvalli VK, Penas-Prado M, Garcia MM. Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab079. PMID: 34377987; PMCID: PMC8350154.
      Citations: 1     
    26. Mellinghoff IK, Penas-Prado M, Peters KB, Burris HA, Maher EA, Janku F, Cote GM, de la Fuente MI, Clarke JL, Ellingson BM, Chun S, Young RJ, Liu H, Choe S, Lu M, Le K, Hassan I, Steelman L, Pandya SS, Cloughesy TF, Wen PY. Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial. Clin Cancer Res. 2021 08 15; 27(16):4491-4499. PMID: 34078652; PMCID: PMC8364866.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    27. Al Feghali KA, Randall JW, Liu DD, Wefel JS, Brown PD, Grosshans DR, McAvoy SA, Farhat MA, Li J, McGovern SL, McAleer MF, Ghia AJ, Paulino AC, Sulman EP, Penas-Prado M, Wang J, de Groot J, Heimberger AB, Armstrong TS, Gilbert MR, Mahajan A, Guha-Thakurta N, Chung C. Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab073. PMID: 34337411; PMCID: PMC8320688.
      Citations:    
    28. Rogers JL, Vera E, Acquaye A, Briceno N, Jammula V, King AL, Leeper H, Quezado MM, Gonzalez Alarcon J, Boris L, Burton E, Celiku O, Choi A, Christ A, Crandon S, Grajkowska E, Leggiero N, Lollo N, Penas-Prado M, Reyes J, Siegel C, Theeler BJ, Timmer M, Wall K, Wu J, Aldape K, Gilbert MR, Armstrong TS. Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study. Neurooncol Pract. 2021 Aug; 8(4):460-474. PMID: 34277024; PMCID: PMC8278352.
      Citations: 2     
    29. Wu J, Yuan Y, Long Priel DA, Fink D, Peer CJ, Sissung TM, Su YT, Pang Y, Yu G, Butler MK, Mendoza TR, Vera E, Ahmad S, Bryla C, Lindsley M, Grajkowska E, Mentges K, Boris L, Antony R, Garren N, Siegel C, Lollo N, Cordova C, Aboud O, Theeler BJ, Burton EM, Penas-Prado M, Leeper H, Gonzales J, Armstrong TS, Calvo KR, Figg WD, Kuhns DB, Gallin JI, Gilbert MR. Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas. Clin Cancer Res. 2021 06 15; 27(12):3298-3306. PMID: 33785481; PMCID: PMC8197750.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    30. Yu G, Butler MK, Abdelmaksoud A, Pang Y, Su YT, Rae Z, Dadkhah K, Kelly MC, Song YK, Wei JS, Terabe M, Atony R, Mentges K, Theeler BJ, Penas-Prado M, Butman J, Camphausen K, Zaghloul KA, Nduom E, Quezado M, Aldape K, Armstrong TS, Gilbert MR, Gulley JL, Khan J, Wu J. Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy. Front Oncol. 2020; 10:601452. PMID: 33520712; PMCID: PMC7841290.
      Citations: 1     
    31. Majd N, Waguespack SG, Janku F, Fu S, Penas-Prado M, Xu M, Alshawa A, Kamiya-Matsuoka C, Raza SM, McCutcheon IE, Naing A. Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study. J Immunother Cancer. 2020 12; 8(2). PMID: 33427689; PMCID: PMC7757504.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    32. Penas-Prado M, Armstrong TS, Gilbert MR. Proposed Additions to the NCCN Guidelines for Adult Medulloblastoma. J Natl Compr Canc Netw. 2020 11; 18(11):1579-1584. PMID: 33152706.
      Citations: 2     Fields:    Translation:HumansCells
    33. Sen S, Tanaka R, Khatua S, Zaky W, Janku F, Penas-Prado M, Weathers SP, Behrang A, Roszik J, Subbiah V. Dual inhibition of BRAF and mTOR in BRAFV600E -mutant pediatric, adolescent, and young adult brain tumors. Cold Spring Harb Mol Case Stud. 2020 08; 6(4). PMID: 32843426; PMCID: PMC7476413.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    34. Penas-Prado M, Theeler BJ, Cordeiro B, Dunkel IJ, Hau P, Mahajan A, Robinson GW, Willmarth N, Aboud O, Aldape K, Butman JA, Gajjar A, Kelly W, Rao G, Raygada M, Siegel C, Romo CG, Armstrong TS, Gilbert MR, NCI-CONNECT Adult Medulloblastoma Workshop . Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma Workshop. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa097. PMID: 33005896; PMCID: PMC7518566.
      Citations: 4     
    35. Penas-Prado M, Armstrong TS, Gilbert MR. Letter to the Editor Re: Mohile et al. Neuro Oncol. 2020 07 07; 22(7):1048-1049. PMID: 32343803; PMCID: PMC7339877.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    36. Lee EQ, Weller M, Sul J, Bagley SJ, Sahebjam S, van den Bent M, Ahluwalia M, Campian JL, Galanis E, Gilbert MR, Holdhoff M, Lesser GJ, Lieberman FS, Mehta MP, Penas-Prado M, Schreck KC, Strowd RE, Vogelbaum MA, Walbert T, Chang SM, Nabors LB, Grossman S, Reardon DA, Wen PY. Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients. Neuro Oncol. 2020 05 15; 22(5):601-612. PMID: 31974566; PMCID: PMC7229255.
      Citations: 13     Fields:    Translation:Humans
    37. Nam JY, Gilbert A, Cachia D, Mandel J, Fuller GN, Penas-Prado M, de Groot J, Kamiya-Matsuoka C. Pineal parenchymal tumor of intermediate differentiation: a single-institution experience. Neurooncol Pract. 2020 Dec; 7(6):613-619. PMID: 33312675; PMCID: PMC7716182.
      Citations: 3     
    38. Weathers SP, Penas-Prado M, Pei BL, Ling X, Kassab C, Banerjee P, Bdiwi M, Shaim H, Alsuliman A, Shanley M, de Groot JF, O'Brien BJ, Harrison R, Majd N, Kamiya-Matsuoka C, Fuller GN, Huse JT, Chi L, Rao G, Weinberg JS, Lang FF, Sawaya R, Shpall EJ, Rezvani K, Heimberger AB. Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial. Clin Cancer Res. 2020 07 15; 26(14):3565-3577. PMID: 32299815; PMCID: PMC9347965.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    39. de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O'Brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, Zhou S, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger AB. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549. PMID: 31755915; PMCID: PMC7158647.
      Citations: 41     Fields:    Translation:HumansCells
    40. Rowe L, Vera E, Acquaye A, Crandon S, Shah V, Bryla C, Wu J, Wall K, Siegel C, Reyes J, Penas-Prado M, Leggiero N, Cordova C, Burton E, Antony R, Boris L, Aboud O, Vyas Y, Mathen P, Gilbert M, Camphausen K, Mendoza T, Armstrong T. The prevalence of altered body image in patients with primary brain tumors: an understudied population. J Neurooncol. 2020 Apr; 147(2):397-404. PMID: 32096067; PMCID: PMC7136178.
      Citations: 2     Fields:    Translation:Humans
    41. Theeler BJ, Dalal Y, Monje M, Shilatifard A, Aboud O, Camphausen K, Cordova C, Finch E, Heiss JD, Packer RJ, Romo CG, Aldape K, Penas-Prado M, Armstrong T, Gilbert MR, Suv? ML. NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop Proceedings. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa007. PMID: 32642676; PMCID: PMC7212875.
      Citations: 3     
    42. Penas-Prado M, Wu J, Cahill DP, Brat DJ, Costello JF, Kluetz PG, Cairncross JG, van den Bent M, Verhaak RGW, Aboud O, Burger P, Chang SM, Cordova C, Huang RY, Rowe LS, Taphoorn MJB, Gilbert MR, Armstrong TS, NCI-CONNECT Oligodendroglioma Workshop . Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma Workshop. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdz048. PMID: 33289010; PMCID: PMC7212866.
      Citations: 2     
    43. Penas-Prado M, Armstrong TS, Gilbert MR. Progress in rare central nervous system tumors. Curr Opin Neurol. 2019 12; 32(6):895-906. PMID: 31577601.
      Citations: 3     Fields:    Translation:Humans
    44. Santos-Pinheiro F, Penas-Prado M, Kamiya-Matsuoka C, Waguespack SG, Mahajan A, Brown PD, Shah KB, Fuller GN, McCutcheon IE. Treatment and long-term outcomes in pituitary carcinoma: a cohort study. Eur J Endocrinol. 2019 Oct; 181(4):397-407. PMID: 31349217.
      Citations: 9     Fields:    Translation:Humans
    45. Lee EQ, Chukwueke UN, Hervey-Jumper SL, de Groot JF, Leone JP, Armstrong TS, Chang SM, Arons D, Oliver K, Verble K, Musella A, Willmarth N, Alexander BM, Bates A, Doherty L, Galanis E, Gaffey S, Halkin T, Friday BE, Fouladi M, Lin NU, Macdonald D, Mehta MP, Penas-Prado M, Vogelbaum MA, Sahebjam S, Sandak D, van den Bent M, Weller M, Reardon DA, Wen PY. Barriers to accrual and enrollment in brain tumor trials. Neuro Oncol. 2019 09 06; 21(9):1100-1117. PMID: 31175826; PMCID: PMC7594546.
      Citations: 27     Fields:    Translation:Humans
    46. Majd N, Penas-Prado M. Updates on Management of Adult Medulloblastoma. Curr Treat Options Oncol. 2019 06 24; 20(8):64. PMID: 31236711.
      Citations: 15     Fields:    Translation:Humans
    47. Harrison RA, Anderson MD, Cachia D, Kamiya-Matsuoka C, Weathers SS, O'Brien BJ, Penas-Prado M, Yung WKA, Wu J, Yuan Y, de Groot JF. Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center. Eur J Cancer. 2019 05; 112:83-93. PMID: 30951926.
      Citations: 7     Fields:    Translation:Humans
    48. Cavaletti G, Cornblath DR, Merkies ISJ, Postma TJ, Rossi E, Alberti P, Bruna J, Argyriou AA, Briani C, Velasco R, Kalofonos HP, Pace A, Faber CG, Lalisang RI, Brandsma D, Koeppen S, Kerrigan S, Schenone A, Grisold W, Mazzeo A, Padua L, Dorsey SG, Penas-Prado M, Valsecchi MG, CI-PeriNomS Group, Psimaras D, Ricard D. Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst. 2019 03; 24(1):111-119. PMID: 30672664.
      Citations: 3     Fields:    Translation:Humans
    49. Maraka S, Groves MD, Penas-Prado M. Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma. Cancer. 2019 04 15; 125(8):1385-1386. PMID: 30707757.
      Citations: 2     Fields:    Translation:Humans
    50. Majd NK, Metrus NR, Santos-Pinheiro F, Trevino CR, Fuller GN, Huse JT, Chung C, Ketonen L, Anderson MD, Penas-Prado M. RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report. Cancer Genet. 2019 02; 231-232:41-45. PMID: 30803556.
      Citations:    Fields:    Translation:Humans
    51. Lassman AB, van den Bent MJ, Gan HK, Reardon DA, Kumthekar P, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Ansell PJ, Bain E, Holen KD, Maag D, Merrell R. Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial. Neuro Oncol. 2019 01 01; 21(1):106-114. PMID: 29982805; PMCID: PMC6303422.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    52. Yeboa DN, Yu JB, Liao E, Huse J, Penas-Prado M, Kann BH, Sulman E, Grosshans D, Contessa J. Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas. Clin Transl Radiat Oncol. 2019 Feb; 15:46-52. PMID: 30656222; PMCID: PMC6329703.
      Citations: 3     
    53. Harrison RA, Kesler SR, Johnson JM, Penas-Prado M, Sullaway CM, Wefel JS. Neurocognitive dysfunction in adult cerebellar medulloblastoma. Psychooncology. 2019 01; 28(1):131-138. PMID: 30315720.
      Citations: 7     Fields:    Translation:Humans
    54. Maraka S, Groves MD, Mammoser AG, Melguizo-Gavilanes I, Conrad CA, Tremont-Lukats IW, Loghin ME, O'Brien BJ, Puduvalli VK, Sulman EP, Hess KR, Aldape KD, Gilbert MR, de Groot JF, Alfred Yung WK, Penas-Prado M. Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. Cancer. 2019 02 01; 125(3):424-433. PMID: 30359477; PMCID: PMC7180384.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    55. Ileana Dumbrava E, Smith V, Alfattal R, El-Naggar AK, Penas-Prado M, Tsimberidou AM. Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation Therapy. J Immunother. 2018 09; 41(7):336-339. PMID: 29787423; PMCID: PMC6086752.
      Citations: 4     Fields:    Translation:Humans
    56. Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM, Undiagnosed Diseases Network, Dhar SU. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma. Neurol Genet. 2018 Aug; 4(4):e248. PMID: 30046660; PMCID: PMC6055357.
      Citations: 4     
    57. Hashimoto Y, Penas-Prado M, Zhou S, Wei J, Khatua S, Hodges TR, Sanai N, Xiu J, Gatalica Z, Kim L, Kesari S, Rao G, Spetzler D, Heimberger A. Rethinking medulloblastoma from a targeted therapeutics perspective. J Neurooncol. 2018 Sep; 139(3):713-720. PMID: 29869738; PMCID: PMC6132970.
      Citations: 7     Fields:    Translation:Humans
    58. Ballester LY, Penas-Prado M, Leeds NE, Huse JT, Fuller GN. FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia. Cold Spring Harb Mol Case Stud. 2018 04; 4(2). PMID: 29610389; PMCID: PMC5880259.
      Citations: 7     Fields:    Translation:HumansCells
    59. Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. J Neurooncol. 2018 Mar; 137(1):39-47. PMID: 29404979; PMCID: PMC6020014.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    60. van den Bent M, Gan HK, Lassman AB, Kumthekar P, Merrell R, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Bain E, Ansell PJ, Holen KD, Maag D, Reardon DA. Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study. Cancer Chemother Pharmacol. 2017 Dec; 80(6):1209-1217. PMID: 29075855; PMCID: PMC5686264.
      Citations: 53     Fields:    Translation:HumansCTClinical Trials
    61. Penas-Prado M, de Groot J. CATNON interim results: another triumph of upfront chemotherapy in glioma. Neuro Oncol. 2017 10 01; 19(10):1287-1288. PMID: 28922864; PMCID: PMC5596163.
      Citations: 1     Fields:    Translation:Humans
    62. Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro Oncol. 2017 05 01; 19(5):669-677. PMID: 28453749; PMCID: PMC5464437.
      Citations: 69     Fields:    Translation:Humans
    63. Chang S, Zhang P, Cairncross JG, Gilbert MR, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Schultz C, Hunter G, Mehta M, Bahary JP, Belanger K. Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. Neuro Oncol. 2017 02 01; 19(2):252-258. PMID: 27994066; PMCID: PMC5463834.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    64. Penas-Prado M. Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting. Am Soc Clin Oncol Educ Book. 2017; 37:187-191. PMID: 28561706.
      Citations: 2     Fields:    Translation:Humans
    65. Gilbert MR, Pugh SL, Aldape K, Sorensen AG, Mikkelsen T, Penas-Prado M, Bokstein F, Kwok Y, Lee RJ, Mehta M. NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma. J Neurooncol. 2017 01; 131(1):193-199. PMID: 27770279; PMCID: PMC5263144.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    66. Kamiya-Matsuoka C, Cachia D, Waguespack SG, Crane CH, Mahajan A, Brown PD, Nam JY, McCutcheon IE, Penas-Prado M. Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary. 2016 Aug; 19(4):415-21. PMID: 27106209; PMCID: PMC5215904.
      Citations: 6     Fields:    Translation:Humans
    67. Weathers SP, Han X, Liu DD, Conrad CA, Gilbert MR, Loghin ME, O'Brien BJ, Penas-Prado M, Puduvalli VK, Tremont-Lukats I, Colen RR, Yung WKA, de Groot JF. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. J Neurooncol. 2016 09; 129(3):487-494. PMID: 27406589; PMCID: PMC5021605.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    68. Cachia D, Jalali A, Cykowski MD, Penas-Prado M, Langford LA, Li J, Shah K, Weinberg JS, Strickland BA. Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case Report. Neurosurgery. 2016 Mar; 78(3):E466-73. PMID: 26352098.
      Citations: 1     Fields:    Translation:Humans
    69. Kim DW, Barcena E, Mehta UN, Rohlfs ML, Kumar AJ, Penas-Prado M, Kim KB. Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report. BMC Cancer. 2015 May 13; 15:400. PMID: 25962795; PMCID: PMC4440312.
      Citations: 15     Fields:    Translation:Humans
    70. Sarandeses P, Penas-Prado M, Ramos A, Carro E, Villarejo-Galende A, Hern?ndez-La?n A, Hern?ndez-Mart?nez AC, Ricoy JR, Hern?ndez-Gallego J. PET-Florbetapir findings in primary cerebral amyloidoma. J Neurol. 2015; 262(4):1052-4. PMID: 25605437.
      Citations: 2     Fields:    Translation:Humans
    71. Cachia D, Wani K, Penas-Prado M, Olar A, McCutcheon IE, Benjamin RS, Armstrong TS, Gilbert MR, Aldape KD. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathol. 2015 Apr; 32(2):105-11. PMID: 25388523; PMCID: PMC4400240.
      Citations: 9     Fields:    Translation:HumansCells
    72. Cachia D, Prado MP, Theeler B, Hamilton J, McCutcheon I, Fuller GN. Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report. Clin Neuropathol. 2014 Nov-Dec; 33(6):407-11. PMID: 24986181.
      Citations: 6     Fields:    Translation:Humans
    73. Cachia D, Singh C, Tetzlaff MT, Penas-Prado M. Middle cerebral artery territory infarct due to Cryptococcus infectionstitle: an uncommon indication for cerebrospinal fluid analysis in stroke patients. Diagn Cytopathol. 2015 Aug; 43(8):632-4. PMID: 25352313.
      Citations:    Fields:    Translation:HumansAnimals
    74. Penas-Prado M, Hess KR, Fisch MJ, Lagrone LW, Groves MD, Levin VA, De Groot JF, Puduvalli VK, Colman H, Volas-Redd G, Giglio P, Conrad CA, Salacz ME, Floyd JD, Loghin ME, Hsu SH, Gonzalez J, Chang EL, Woo SY, Mahajan A, Aldape KD, Yung WK, Gilbert MR, MD Anderson Community Clinical Oncology Program, Brain Tumor Trials Collaborative. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol. 2015 Feb; 17(2):266-73. PMID: 25239666; PMCID: PMC4288521.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    75. Farnia B, Allen PK, Brown PD, Khatua S, Levine NB, Li J, Penas-Prado M, Mahajan A, Ghia AJ. Clinical outcomes and patterns of failure in pineoblastoma: a 30-year, single-institution retrospective review. World Neurosurg. 2014 Dec; 82(6):1232-41. PMID: 25045788.
      Citations: 16     Fields:    Translation:Humans
    76. Chang EL, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD, Ghia AJ. Intracranial hemangiopericytoma: patterns of failure and the role of radiation therapy. Neurosurgery. 2013 Oct; 73(4):624-30; discussion 630-1. PMID: 23839520.
      Citations: 16     Fields:    Translation:Humans
    77. Anderson MD, Theeler BJ, Penas-Prado M, Groves MD, Yung WK. Bevacizumab use in disseminated choroid plexus papilloma. J Neurooncol. 2013 Sep; 114(2):251-3. PMID: 23761024.
      Citations: 3     Fields:    Translation:Humans
    78. Yust-Katz S, Garciarena P, Liu D, Yuan Y, Ibrahim N, Yerushalmi R, Penas-Prado M, Groves MD. Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis. J Neurooncol. 2013 Sep; 114(2):229-35. PMID: 23756727.
      Citations: 21     Fields:    Translation:Humans
    79. Ghia AJ, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD. Intracranial hemangiopericytoma and the role of radiation therapy: a population based analysis. Neurosurgery. 2013 Feb; 72(2):203-9. PMID: 23149953.
      Citations: 15     Fields:    Translation:Humans
    80. Fakhreddine MH, Mahajan A, Penas-Prado M, Weinberg J, McCutcheon IE, Puduvalli V, Brown PD. Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. Neuro Oncol. 2013 Apr; 15(4):406-12. PMID: 23322747; PMCID: PMC3607259.
      Citations: 20     Fields:    Translation:Humans
    81. Cavaletti G, Cornblath DR, Merkies ISJ, Postma TJ, Rossi E, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Pace A, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG, CI-PeriNomS Group, Mazzeo A, Pace A, Pessino A, Schenone A, Toscano A, Argyriou AA, Brouwer B, Frigeni B, Piras B, Briani C, Dalla Torre C, Dominguez Gonzalez C, Faber CG, Tomasello C, Binda D, Brandsma D, Cortinovis D, Psimaras D, Ricard D, Storey D, Cornblath DR, Lindeck Pozza E, Rossi E, Vanhoutte EK, Lanzani F, Pastorelli F, Altavilla G, Cavaletti G, Granata G, Kalofonos HP, Ghignotti I, Merkies ISJ, Bruna J, Hense J, Heimans JJ, Mattavelli L, Padua L, Reni L, Bakkers M, Boogerd M, Campagnolo M, Cazzaniga M, Eurelings M, Leandri M, Lucchetta M, Penas Prado M, Russo M, Valsecchi MG, Piatti ML, Alberti P, Bidoli P, Grant R, Plasmati R, Velasco R, Lalisang RI, Meijer RJ, Fabbri S, Dorsey SG, Galimberti S, Kerrigan S, Koeppen S, Postma TJ, Boogerd W, Grisold W, Psimaras D, Ricard D, Gali? E, Gali? E. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol. 2013 Feb; 24(2):454-462. PMID: 22910842; PMCID: PMC3551481.
      Citations: 90     Fields:    Translation:Humans
    82. Penas-Prado M, Armstrong TS, Gilbert MR. Glioblastoma. Handb Clin Neurol. 2012; 105:485-506. PMID: 22230514.
      Citations: 9     Fields:    Translation:Humans
    83. Penas-Prado M, Hilario-Barrio A, Ruiz-Morales J, Sierra-Hidalgo F, Mart?n-Gil L, Herreros-Rodr?guez J. [Cerebral infarctions and leptomeningeal carcinomatosis]. Rev Neurol. 2009 Aug 1-15; 49(3):156. PMID: 19621311.
      Citations: 1     Fields:    Translation:Humans
    84. Penas-Prado M, Loghin ME. Spinal cord compression in cancer patients: review of diagnosis and treatment. Curr Oncol Rep. 2008 Jan; 10(1):78-85. PMID: 18366964.
      Citations: 8     Fields:    Translation:Humans
    85. Penas-Prado M, Gilbert MR. Molecularly targeted therapies for malignant gliomas: advances and challenges. Expert Rev Anticancer Ther. 2007 May; 7(5):641-61. PMID: 17492929.
      Citations: 19     Fields:    Translation:Humans
    86. Porta-Etessam J, Villarejo-Galende A, Moreno-Ramos T, Penas-Prado M, Mart?nez-Salio A, Garc?a-Ramos R, Saiz-D?az RA. [Post-traumatic supraorbital neuralgia: a benign condition]. Rev Neurol. 2007 Jan 16-31; 44(2):89-91. PMID: 17236147.
      Citations: 3     Fields:    Translation:Humans
    87. Penas M, Saiz R, Fern?ndez-Miranda C, de la Pe?a P, G?mez P, G?mez de la C?mara A. [Hyperhomocysteinemia and treatment with antiepileptic drugs. Effects of different doses of folic acid]. Med Clin (Barc). 2005 Apr 16; 124(14):521-4. PMID: 15847747.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    88. Villarejo A, Camacho A, Penas M, Porta-Etessam J, Gonz?lez De La Aleja J, Mart?nez-Salio A. Gabapentin for painful legs and moving toes syndrome. Eur Neurol. 2004; 51(3):180-1. PMID: 15073446.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    89. Galende AV, Camacho A, Gomez-Escalonilla C, Penas M, Ramos A, Juntas R, Esteban J. Lateral medullary infarction secondary to vertebral artery dissection presenting as a trigeminal autonomic cephalalgia. Headache. 2004 Jan; 44(1):70-4. PMID: 14979886.
      Citations: 6     Fields:    Translation:Humans
    90. Penas Prado M, Gonz?lez de la Aleja Tejera J, Gonz?lez Mart?nez V, Rodr?guez Pe?a-Mar?n M. [Spontaneous spinal epidural hematoma]. Neurologia. 2003 Jun; 18(5):285-6. PMID: 12768518.
      Citations:    Fields:    Translation:Humans
    91. Camacho-Salas A, Penas-Prado M, Juntas-Morales R, Gonzalez-de la Aleja J, Ramos A, Villarejo-Galende A, Rodr?guez-Vallejo A. [Spinal epidural abscess in a patient with septicaemia]. Rev Neurol. 2003 Jun 16-30; 36(12):1152-5. PMID: 12833235.
      Citations: 1     Fields:    Translation:Humans
    92. Villarejo A, Camacho A, Moreno T, Penas M, Ruiz J, Garc?a-Ramos R, Juntas R. Cholinergic-dopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol. 2003 May-Jun; 26(3):119-21. PMID: 12782913.
      Citations: 21     Fields:    Translation:Humans
    93. Camacho-Salas A, Penas-Prado M, Mendoza MC, Mateos-Beato F, Villarejo-Galende A, Garc?a-Ramos R, Sim?n de las Heras R. [Unilateral isolated paralysis of the soft palate: a case report and a review of the literature]. Rev Neurol. 2003 Feb 15-28; 36(4):337-9. PMID: 12599130.
      Citations: 4     Fields:    Translation:Humans
    94. Penas M, Lizasoain M, Mart?nez-Salio A, Porta-Etessam J. [Autoimmune meningitis simulating bacterial meningitis]. Enferm Infecc Microbiol Clin. 2002 Dec; 20(10):535-6. PMID: 12433357.
      Citations:    Fields:    Translation:Humans
    95. Penas M, Blanco A, Villarejo A, Juntas R, Miranda P, Mart?nez A. [Subacute combined degeneration of the spinal cord: MR findings]. Neurologia. 2002 Oct; 17(8):447-8. PMID: 12396977.
      Citations: 1     Fields:    Translation:Humans
    96. Penas M, Blanco A, Miranda P, Porta-Etessam J, Posada I, Mart?nez-Salio A. [Brachial plexopathy in varicella of the adults. A case report]. Rev Neurol. 2001 Sep 16-30; 33(6):599-600. PMID: 11727250.
      Citations: 1     Fields:    Translation:Humans
    97. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. Journal of Neuro-Oncology. 1-8.
    98. NRG oncology RTOG 0625. Journal of Neuro-Oncology. 131:193-199.
    99. Spinal Anaplastic Oligodendroglioma with Oligodendrogliomatosis. Neurosurgery. 78:E466-E473.
    100. Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary. 1-7.
    101. Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy. BMC Cancer. 15.
    102. Neuralgia supraorbitaria. Revista de Neurologia. 44:383.
    PENAS-PRADO's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (312)
    Explore
    _
    Co-Authors (60)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _